Kaposi Sarcoma

Kaposi sarcoma is a type of cancer where abnormal cells develop in the skin or the mucous membranes lining the gastrointestinal (GI) tract, spanning from the mouth to the anus and including the stomach and intestines. These tumors typically appear as purple patches or nodules on the skin or mucous membranes and can potentially spread to lymph nodes and lungs. This condition is more prevalent in males and in individuals with weakened immune systems.

Characteristics and Behavior
Symptoms
Causes
Risk Factors
Treatment Options

Characteristics and Behavior

Kaposi Sarcoma can vary in presentation, from indolent skin lesions to aggressive forms that spread rapidly, particularly in immunocompromised individuals.

Symptoms

Symptoms include skin lesions, swelling, and potentially respiratory or gastrointestinal issues if internal organs are involved.

Causes

Kaposi Sarcoma is mainly caused by human herpesvirus 8 (HHV-8), often in combination with immunosuppression, such as in HIV/AIDS patients.

Risk Factors

Risk factors include having HIV/AIDS, receiving an organ transplant, or other conditions that suppress the immune system.

Treatment Options

Treatment approaches for Kaposi sarcoma include:

  • Boosting immune system function: Strengthening the immune system is the primary and most effective therapy for Kaposi sarcoma patients, especially those with immune deficiencies.
  • Antiretroviral therapy (a treatment regimen used to manage infections caused by retroviruses, notably HIV): For AIDS patients, antiretroviral therapy used to manage AIDS can also be effective in treating Kaposi sarcoma. Transplant recipients may be advised to adjust immunosuppressant drugs.
  • Local therapies: Topical treatments like injecting chemotherapy directly into lesions, cryosurgery (surgery that involves the use of extreme cold to destroy abnormal tissues) , excisions (removing by cutting out), phototherapy (using ultraviolet light), or local radiation may be recommended for patients with few small lesions.
  • Chemotherapy: If immune deficiency improvements don’t lead to improvement, chemotherapy may be necessary. Intravenous or oral chemotherapy may be used.
  • Immunotherapy: This treatment activates the body’s immune system to fight cancer and is being explored for Kaposi sarcoma. Clinical trials and emerging treatment options should be discussed with a healthcare provider.
  • Surgery: Generally not recommended due to ineffectiveness in curing the disease and the risk of lesion recurrence.
Scroll to Top